GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (NAS:OCS) » Definitions » Price-to-Free-Cash-Flow

Oculis Holding AG (Oculis Holding AG) Price-to-Free-Cash-Flow : N/A (As of Jun. 20, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Price-to-Free-Cash-Flow?

As of today (2024-06-20), Oculis Holding AG's share price is $11.75. Oculis Holding AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.62. Hence, Oculis Holding AG's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Oculis Holding AG's Price-to-Free-Cash-Flow or its related term are showing as below:

OCS's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 32.09
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Oculis Holding AG's Free Cash Flow per Share for the three months ended in Mar. 2024 was $-0.41. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-1.62.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -71.40% per year.

During the past 4 years, Oculis Holding AG's highest 3-Year average Free Cash Flow per Share Growth Rate was -71.40% per year. The lowest was -71.40% per year. And the median was -71.40% per year.


Oculis Holding AG Price-to-Free-Cash-Flow Historical Data

The historical data trend for Oculis Holding AG's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Price-to-Free-Cash-Flow Chart

Oculis Holding AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
- - - -

Oculis Holding AG Quarterly Data
Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Oculis Holding AG's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Oculis Holding AG's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oculis Holding AG's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oculis Holding AG's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Oculis Holding AG's Price-to-Free-Cash-Flow falls into.



Oculis Holding AG Price-to-Free-Cash-Flow Calculation

Oculis Holding AG's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=11.75/-1.621
=N/A

Oculis Holding AG's Share Price of today is $11.75.
Oculis Holding AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.62.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Oculis Holding AG  (NAS:OCS) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Oculis Holding AG Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Oculis Holding AG's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Oculis Holding AG (Oculis Holding AG) Business Description

Traded in Other Exchanges
Address
Bahnhofstrasse 7, Zug, CHE, 6300
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Oculis Holding AG (Oculis Holding AG) Headlines

From GuruFocus